Skip to main content
Print Save

WPI 2235 (Tetracycline Hydrochloride 500 mg)

Pill with imprint WPI 2235 is Black & Yellow, Capsule-shape and has been identified as Tetracycline Hydrochloride 500 mg. It is supplied by Watson Pharmaceuticals, Inc.

Tetracycline is used in the treatment of acne; bacterial infection; bladder infection; bronchitis; nongonococcal urethritis and belongs to the drug class tetracyclines. There is positive evidence of human fetal risk during pregnancy. Tetracycline 500 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 2235

Tetracycline hydrochloride 500 mg WPI 2235

Tetracycline Hydrochloride

Imprint
WPI 2235
Strength
500 mg
Color
Black & Yellow
Size
22.00 mm
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Tetracyclines
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals, Inc.
National Drug Code (NDC)
00591-2235 (Discontinued)
Inactive Ingredients
lactose, magnesium stearate, sodium lauryl sulfate, D&C Yellow No. 10, FD&C Blue No. 1, FD&C Red No. 40, gelatin, titanium dioxide, benzyl alcohol, butylparaben, edetate calcium disodium, FD&C Yellow No. 6, methylparaben, propylparaben, silicon dioxide, sodium propionate, dimethicone, water, alcohol, ethylene glycol monoethyl ether, shellac, soya lecithin

Note: Inactive ingredients may vary.

Drug Uses Add to Drug List Print

Get help with Imprint Code FAQs.

Related images for "WPI 2235"

Pill WPI 2285 White Capsule-shape is Propafenone Hydrochloride Extended-Release
Propafenone Hydrochloride Extended-Release

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer